+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Swine Vaccines Market Size, Share & Trends Analysis Report, by Product (Recombinant, Inactivated), by Type (Pseudorabies, Porcine Circovirus Type 2), by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • October 2022
  • Region: Global
  • Grand View Research
  • ID: 5526499
Description Jump to:
The global swine vaccines market size is expected to reach USD 2.3 billion by 2030. The market is anticipated to witness a lucrative CAGR of 4.9% from 2022 to 2030. The increasing prevalence and incidence of swine diseases, rising concerns over zoonoses, and strengthening biosecurity measures among swine farms are some of the major factors augmenting the market growth. In addition, the initiatives taken by government and animal healthcare organizations in spreading disease awareness and supporting vaccination drives are further propelling the market growth during the projected period.

The Covid-19 pandemic has directly or indirectly impacted the key player’s swine vaccine business operations and resulted in declined financial performance during the initial time. The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, the simultaneously reported African swine fever outbreaks in several regions pressured the swine vaccine manufacturers with a large demand. In 2020, the OIE reported 9,928 ASF outbreaks in Asia, followed by 4,271 outbreaks in Europe. Hence, considering the situation, the government supported the distribution of swine vaccines with ease of restrictions, which afforded opportunities to rebuild the company’s growth.

In addition, the global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Thus, several countries have banned the use of antibiotics for livestock farming, including preventive treatment procedures. This act has compelled swine farms to adopt antibiotic-free disease preventive approaches such as vaccination. Furthermore, growing investments by key players to develop advanced products for better diagnosis are likely to propel market growth. For instance, in May 2020, Indian Immunologicals Ltd. introduced the Classical Swine Fever vaccine under the brand name ‘Raksha Class’, a unique cell culture technology-based vaccine developed in cooperation with the Indian Veterinary Research Institute, Bareilly.

Key players in the market are implementing various strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, among others to maintain a competitive edge in the market. For instance, In March 2022, Ceva launched the sow vaccine, a vaccine containing seven antigens used to treat neonatal diarrhea.

Swine Vaccines Market Report Highlights

  • The PRRS (Porcine Reproductive and Respiratory Syndrome) segment accounted for the largest revenue share in 2021 by type segment owing to its large prevalence in major swine-raising countries. The disease has been considered an epidemic for over 30 years in the U.S. and more than 20 years in China, the leading swine industry
  • By product, the inactivated vaccines segment held the largest market share in 2021. These vaccines are more stable than live attenuated vaccines and can provide swine with better immunization. They prevent pathogen replication and therefore do not possess the risk of virulence reversion
  • Asia Pacific accounted for the largest market share in 2021 and is expected to grow at the fastest CAGR. Key factors contributing to this notable share include the presence of leading swine production countries such as China coupled with a large meat-consuming population and wide requirement for vaccines to curb current rising disease outbreaks among Asian swine herds
  • The market is fairly competitive owing to the presence of major players such as Zoetis, Merck, Ceva, Boehringer Ingelheim International GmbH, Elanco, and Virbac among others. The various strategic initiatives implemented by companies such as acquisitions, collaborations, product launches, and partnerships are greatly contributing to the growth of the market

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information/Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Bottom - Up Market Estimation
1.6.1.2 Top - Down Market Estimation
1.6.2 Global Market: Cagr Calculation
1.7 List Of Secondary Sources
Chapter 2 Executive Summary
2.1 Swine Vaccines Market Outlook
2.1.1 Segment Outlook
2.1.2 Regional Outlook
2.1.3 Competitive Outlook
2.2 Swine Vaccines Market Snapshot, 2021
Chapter 3 Swine Vaccines Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration And Growth Prospect Mapping, By Product Type, 2021
3.3 Swine Vaccines Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Rising Concern About Zoonoses & Strengthening Biosecurity
3.3.1.2 Vaccines Act As An Alternative To Antibiotics
3.3.1.3 Technological Advancements
3.3.1.4 Regulatory Mandates
3.3.2 Market Restraint Analysis
3.3.2.1 Short Product Exclusivity Period
3.3.2.2 Religious And Cultural Restrictions
3.3.2.3 Supply Bans On Live Pigs And Pork Products
3.4 Industry Analysis
3.4.1 Porter’s Analysis
3.4.1.1 Threat Of New Entrants: Low - Moderate
3.4.1.2 Threat Of Substitutes: Moderate To High
3.4.1.3 Bargaining Power Of Buyers: Moderate
3.4.1.4 Bargaining Power Of Suppliers: Low
3.4.1.5 Competitive Rivalry: High
3.4.2 Pestel Analysis
3.4.2.1 Political & Legal Landscape
3.4.2.2 Economic
3.4.2.3 Social
3.4.2.4 Technological
3.4.2.5 Environmental
3.5 Regulatory Framework
3.5.1 North America
3.5.2 Europe
3.5.3 Apac
3.5.4 Latam
3.5.5 Rest Of The World
3.6 Product Pipeline Analysis
Chapter 4 Swine Vaccines Market: Covid - 19 Impact Analysis
4.1 Covid - 19 Impact Analysis
Chapter 5 Product Estimates & Trend Analysis, 2017 - 2030 (USD Million)
5.1 Product Movement Analysis, 2017 - 2030 (USD Million)
5.2 Swine Vaccines Market Share Analysis, 2021 & 2030
5.2.1 Attenuated Live Vaccines
5.2.1.1 Attenuated Live Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.2 Inactivated Vaccines
5.2.2.1 Inactivated Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.3 Subunit Vaccines
5.2.3.1 Subunit Vaccines Market estimates and forecasts, 2017 - 2030 (USD Million)
5.2.4 Dna Vaccines
5.2.4.1 Dna Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.5 Recombinant Vaccines
5.2.5.1 Recombinant Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 6 Type Estimates & Trend Analysis, 2017 - 2030 (USD Million)
6.1 Type Movement Analysis, 2017 - 2030 (USD Million)
6.2 Swine Vaccines Market Share Analysis, 2021 & 2030
6.2.1 Swine Influenza
6.2.1.1 Swine Influenza Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.2 Classical Swine Fever
6.2.2.1 Classical Swine Fever Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.3 Porcine Parvovirus
6.2.3.1 Porcine Parvovirus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.4 Porcine Circovirus Type 2
6.2.4.1 Porcine Circovirus Type 2 Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.5 M.Hyo
6.2.5.1 M.Hyo Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.6 Actinobacillus Pleuropneumonia
6.2.6.1 Actinobacillus Pleuropneumonia Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.7 PRRS
6.2.7.1 PRRS Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.8 Foot & Mouth Disease
6.2.8.1 Foot & Mouth Disease Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.9 Pseudorabies
6.2.9.1 Pseudorabies Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.10 Porcine Epidemic Diarrhea
6.2.10.1 Pedv Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.11 Others
6.2.11.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 7 Regional Estimates & Trend Analysis, 2017 - 2030 (USD Million)
7.1 Regional Market Snapshot
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 North America
7.3.1 North America Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.3.2 U.S.
7.3.2.1 U.S. Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.3.3 Canada
7.3.3.1 Canada Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.4 Europe
7.4.1 Europe Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.4.2 France
7.4.2.1 France Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.4.3 Germany
7.4.3.1 Germany Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.4.4 Spain
7.4.4.1 Spain Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.4.5 Italy
7.4.5.1 Italy Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.4.6 U.K.
7.4.6.1 UK Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.5.2 India
7.5.2.1 India Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.3 China
7.5.3.1 China Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.4 Japan
7.5.4.1 Japan Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.5 Australia
7.5.5.1 Australia Swine Vaccines Market Estimates and Forecasts, 2017 - 2030 (USD Million)
7.5.6 South Korea
7.5.6.1 South Korea Swine Vaccines Market Estimates and Forecasts, 2017 - 2030 (USD million)
7.6 Latin America
7.6.1 Latin America Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.6.2 Brazil
7.6.2.1 Brazil Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.6.3 Mexico
7.6.3.1 Mexico Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.6.4 Argentina
7.6.4.1 Argentina Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.7 MEA
7.7.1 MEA Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.7.2 South Africa
7.7.2.1 South Africa Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Saudi Arabia Swine Vaccines Market estimates and forecasts 2017 - 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Market Participation Categorization
8.2 Public Companies
8.2.1 Company Market Position Analysis
8.2.2 Heat Map Analysis
8.3 Private Companies
8.3.1 List Of Key Companies
Chapter 9 Swine Vaccines Market - Company Profiles
9.1 Merck & Co., Inc.
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Ceva
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 Zoetis
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Elanco
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Indian Immunologicals Ltd.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Biogénesis Bagó
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Phibro Animal Health Corporation
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 KM Biologics (Meiji Holdings Co., Ltd)
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.10 HIPRA
9.10.1 Company Overview
9.10.2 Product Benchmarking
9.10.3 Strategic Initiatives
9.11 Virbac
9.11.1 Company Overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 North America Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 3 North America Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 4 U.S. Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 5 U.S. Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 6 Canada Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 7 Canada Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 8 Europe Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 9 Europe Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 10 U.K. Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 11 U.K. Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 12 Germany Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 13 Germany Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 14 France Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 15 France Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 16 Italy Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 17 Italy Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 18 Spain Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 19 Spain Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 20 Asia Pacific Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 21 Asia Pacific Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 22 Japan Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 23 Japan Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 24 China Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 25 China Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 26 India Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 27 India Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 28 Australia Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 29 Australia Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 30 South Korea Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 31 South Korea Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 32 Latin America Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 33 Latin America Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 34 Brazil Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 35 Brazil Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 36 Mexico Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 37 Mexico Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 38 Argentina Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 39 Argentina Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 40 MEA Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 41 MEA Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 42 South Africa Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 43 South Africa Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 44 Saudi Arabia Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 45 Saudi Arabia Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
Table 46 Global Swine Vaccines market revenues, by type, 2017-2030 (Revenue, USD Million)
Table 47 Global Swine Vaccines market revenues, by product, 2017-2030 (Revenue, USD Million)
List of Figures
Fig. 1 Swine Vaccines market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 General methodology for a Commodity flow analysis of Animal Health markets
Fig. 9 Commodity flow analysis
Fig. 10 Swine Vaccines Market Snapshot (2021, USD Million)
Fig. 11 Parent market outlook
Fig. 12 Ancillary market outlook
Fig. 13 Penetration & growth prospect mapping, by product type, 2021
Fig. 14 Swine Vaccines market dynamics analysis
Fig. 15 Swine Vaccines market driver analysis
Fig. 16 Swine Vaccines market restraint impact
Fig. 17 Swine vaccines market: Product movement analysis, 2017-2030 (USD Million)
Fig. 18 Swine vaccines market share analysis, 2021 & 2030
Fig. 19 Attenuated live vaccines market, 2017-2030 (USD Million)
Fig. 20 Inactivated vaccines market, 2017-2030 (USD Million)
Fig. 21 Subunit vaccines market, 2017-2030 (USD Million)
Fig. 22 DNA vaccines market, 2017-2030 (USD Million)
Fig. 23 Recombinant vaccines market, 2017-2030 (USD Million)
Fig. 24 Swine vaccines market: Type movement analysis, 2017-2030 (USD Million)
Fig. 25 Swine vaccines market share analysis, 2021 & 2030
Fig. 26 Swine influenza market, 2017-2030 (USD Million)
Fig. 27 Classical swine fever market, 2017-2030 (USD Million)
Fig. 28 Porcine parvovirus market, 2017-2030 (USD Million)
Fig. 29 Porcine circovirus type 2 market, 2017-2030 (USD Million)
Fig. 30 M.Hyo market, 2017-2030 (USD Million)
Fig. 31 Actinobacillus pleuropneumonia market, 2017-2030 (USD Million)
Fig. 32 PRRS market, 2017-2030 (USD Million)
Fig. 33 Foot & mouth disease market, 2017-2030 (USD Million)
Fig. 34 Pseudorabies market, 2017-2030 (USD Million)
Fig. 35 PEDV market, 2017-2030 (USD Million)
Fig. 36 Others market, 2017-2030 (USD Million)
Fig. 37 Regional Market Snapshot
Fig. 38 Regional Market Share Analysis, 2021 & 2030
Fig. 39 Swine Population in North America (Unit in heads)
Fig. 40 North America Swine Vaccines market, 2017-2030 (USD Million)
Fig. 41 U.S. Swine Vaccines market, 2017-2030 (USD Million)
Fig. 42 Canada Swine Vaccines market, 2017-2030 (USD Million)
Fig. 43 Europe Swine Vaccines market, 2017-2030 (USD Million)
Fig. 44 France Swine Vaccines market, 2017-2030 (USD Million)
Fig. 45 Germany Swine Vaccines market, 2017-2030 (USD Million)
Fig. 46 Swine population in Spain (Unit in heads)
Fig. 47 Spain Swine Vaccines market, 2017-2030 (USD Million)
Fig. 48 Italy Swine Vaccines market, 2017-2030 (USD Million)
Fig. 49 U.K. Swine Vaccines market, 2017-2030 (USD Million)
Fig. 50 Swine population in Asia Pacific (in Millions of heads)
Fig. 51 Asia Pacific Swine Vaccines market, 2017-2030 (USD Million)
Fig. 52 India Swine Vaccines market, 2017-2030 (USD Million)
Fig. 53 Swine population in China (in Millions of heads)
Fig. 54 China Swine Vaccines market, 2017-2030 (USD Million)
Fig. 55 Japan Swine Vaccines market, 2017-2030 (USD Million)
Fig. 56 Latin America swine vaccines market, 2017-2030 (USD Million)
Fig. 57 Swine population in Brazil (estimated), 2017-2021 (in Millions of heads)
Fig. 58 Brazil swine vaccines market, 2017-2030 (USD Million)
Fig. 59 Estimated Swine population in Mexico, 2017-2021 (Units in Heads)
Fig. 60 Mexico swine vaccines market, 2017-2030 (USD Million)
Fig. 61 Estimated Swine population in Argentina, 2017-2021 (Units in Heads)
Fig. 62 Argentina swine vaccines market, 2017-2030 (USD Million)
Fig. 63 MEA swine vaccines market, 2017-2030 (USD Million)
Fig. 64 Estimated Swine population in South Africa, 2017-2021 (Units in Heads)
Fig. 65 South Africa swine vaccines market, 2017-2030 (USD Million)
Fig. 66 Saudi Arabia Swine Vaccines Market, 2017-2030 (USD Million)
Fig. 67 Saudi Arabia Swine vaccines market, 2017-2030 (USD Million)
Fig. 68 Market participation categorization
Fig. 69 Market leaders and innovators
Fig. 70 Public company market position analysis

Companies Mentioned

  • Merck & Co. Inc.
  • Ceva
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Indian Immunologicals Ltd.
  • Biogénesis Bagó
  • Phibro Animal Health Corporation
  • Km Biologics (Meiji Holdings Co. Ltd)
  • Hipra
  • Virbac

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedOctober 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 1.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.3 Billion
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Swine Vaccines Market by Product, Type, Target Disease - Global Forecast 2025-2030 - Product Image

Swine Vaccines Market by Product, Type, Target Disease - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Swine Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Swine Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Swine Vaccines Global Market Report 2024 - Product Image

Swine Vaccines Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Foot and Mouth Disease Vaccine Market Size, Share and Trends Analysis Report by Animal (Cattle, Sheep & Goat, Swine), Vaccine (Modified/Attenuated Live), Distribution Channel, and Region 2024-2030 - Product Image

Foot and Mouth Disease Vaccine Market Size, Share and Trends Analysis Report by Animal (Cattle, Sheep & Goat, Swine), Vaccine (Modified/Attenuated Live), Distribution Channel, and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Swine Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology - Product Image

Swine Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

  • Report
  • 91 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.